MCL1 and gastric cancer: Loss and functional gain assays showed that lncRNA MYOSLID promotes gastric cancer cell proliferation and inhibits apoptosis by acting as a miR‐29c‐3p ceRNA, thereby preventing miR‐29c‐3p from binding to the target protein MCL‐1 (35).